Home

The Australian Advantage

Headquartered in the fastest growing clinical trials market in the world, Accelagen is located in Australia’s second biggest city — Melbourne, Victoria. Working flexibly and collaboratively with additional team members based along the East Coast of Australia and partners in growing markets overseas, we are proud to lead a rapidly scaling sector Down Under.

 

As a company headquartered in Australia, Accelagen is both locally positioned and globally adept, working with companies big and small to accelerate the future of human health and wellness around the world.

With over a decade of delivered success, our experience is widely varied across the health, wellness and disease spectrum, offering end-to-end services across Clinical Trials, Regulatory Affairs and Biometrics, as well as Strategic Consultation services to support you through all stages of the product life cycle.

Why choose Australia?

With a population of around 25 million citizens, Australia has the size, diversity and strategic location to offer high quality clinical trial management, world-leading research facilities and smooth pathways to market.

Case studies

Case studies and success stories across our portfolio of clients and clinical trials. Filter by: Show All case studies Negative to Positive: How we turned

Read More »

Latest news

Keep up to date with the latest news from Accelagen Filter by: All Announcements Company updates Staff announcements Accelagen Staff Announcement: Amritha Vangur Today we

Read More »

Careers

Join our flexible, friendly and rapidly growing team Careers at Accelagen At the heart of Accelagen is our people driving who we are and what

Read More »
Access & Proximity

Access and Proximity

Easily accessible via world class transport and air travel, being headquartered in Australia makes us accessible to partners from across in the Asia-Pacific region and the world.
Ethnically Diverse

Ethnically-diverse

Australia has the highest proportion of people born overseas than any other nation with a population over 10 million. Our diversity is our strength and your point of difference.
World-class Infrastructure

World-class Infrastructure

With a leading health care system and well regulated data management practices, Australia has a world-leading Medical Research Infrastructure, particularly in early clinical trial development.

Tax Incentives

Early phase clinical trials in Australia are significantly cheaper than the US, and there are generous R&D Tax Incentives available with support from the Australian Government.

Globally-recognised

Australia is ranked in the Top 5 for biotech innovation and our Clinical Trial Notification (CTN) scheme has been a global benchmark for reducing the regulatory burden on clinical trial sponsors.

Data exclusivity

Australia’s intellectual property system is one of the most secure in the world, and in addition to patent protection, Australia also provides five years of data exclusivity to new pharmaceutical products.

Accelagen offers full CRO services for clinical trials in Australia and beyond